Remote monitoring to adjust heart failure medications
Part of Heart & circulation clinical trials.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have shortness of breath and at least one sign of fluid overload (like fluid on lung X-ray, crackly breath sounds, leg swelling, or high neck vein pressure).
- A blood test (NT-proBNP) done during this hospital stay shows a high level (above 300, or 600 if you have atrial fibrillation).
- Your heart's pumping strength (ejection fraction) is below 40%.
- You are not currently in the hospital for heart failure caused by a blood clot in the lungs, stroke, or recent heart attack.
- You haven't had major heart surgery or a heart device placed in the last month, and none is planned.
- You can use basic electronic devices and have mobile network access where you live.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a remote monitoring device that sends information to your care team to help adjust your heart failure medications. It aims to improve your condition after a hospital stay for heart failure.
This trial tests whether remote monitoring of your implanted heart device can help your doctors better manage your heart failure. It is for people with certain types of pacemakers or defibrillators who are willing to share their device data remotely.
This trial is testing a special monitor (BIOMONITOR) that tracks your heart function and sends data wirelessly to your doctor. It aims to help manage heart failure by catching early signs of trouble so you can get treatment sooner.
This trial tests a virtual “heart failure clinic” and home heart monitoring to help people manage symptoms and outcomes. It may help by catching problems earlier and guiding safer self-care between doctor visits.
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
Hear when a new Acute Heart Failure With Reduced Left Ventricular Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.